| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 16.88× | 16.88× | 16.08× | 18.61× | 24.96× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.32× | 0.32× | 0.34× | 0.37× | 0.31× | ||
| 1.16× | 1.16× | 0.66× | 0.41× | 0.90× | ||
| 0.68× | 0.68× | 0.49× | 0.31× | 0.65× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 24.96 | 18.61 | 16.08 | 16.88 | 16.88 | |
| Asset Turnover | 0.31 | 0.37 | 0.34 | 0.32 | 0.32 | |
| Cash Conversion (CFO/Net Income) | 0.90 | 0.41 | 0.66 | 1.16 | 1.16 | |
| CFO/EBITDA | 0.65 | 0.31 | 0.49 | 0.68 | 0.68 |